Advances In Clinical Trials Research And Evidence Based Decision Making
Funder
National Health and Medical Research Council
Funding Amount
$6,712,859.00
Summary
The NHMRC Clinical Trials Centre at the University of Sydney aims to use clinical trials and methodological research in trials to improve health in Australia and internationally It is a member of many international collaborative trials groups, especially in heart disease and cancer. A particular area of interest is patient preferences and decision making, particularly in cancer. The Clinical Trial Centre is active in using data from its own and other clinical trials in combined analyses to arriv ....The NHMRC Clinical Trials Centre at the University of Sydney aims to use clinical trials and methodological research in trials to improve health in Australia and internationally It is a member of many international collaborative trials groups, especially in heart disease and cancer. A particular area of interest is patient preferences and decision making, particularly in cancer. The Clinical Trial Centre is active in using data from its own and other clinical trials in combined analyses to arrive at better evidence.Read moreRead less
Clinical Trials Advances For Better Health Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$8,012,612.00
Summary
The NHMRC Clinical Trials Centre (CTC) aims to use clinical trials and methodological research in trials to improve health in Australia and internationally. Its research program will initiate major new clinical trials and a comprehensive program of research into trial methods, biostatistical analysis, health outcome analysis and decision analysis. Patient preferences and decision making, particularly in cancer, will be a focus. CTC uses data from its own and other clinical trials in combined ana ....The NHMRC Clinical Trials Centre (CTC) aims to use clinical trials and methodological research in trials to improve health in Australia and internationally. Its research program will initiate major new clinical trials and a comprehensive program of research into trial methods, biostatistical analysis, health outcome analysis and decision analysis. Patient preferences and decision making, particularly in cancer, will be a focus. CTC uses data from its own and other clinical trials in combined analyses to arrive at better evidence. The NHMRC program grant will allow important research studies to be integrated with trials funded from industry and other sources and will maintain the CTC’s internationally competitive research team at the cutting edge of new trial methods and systems.Read moreRead less